Retatrutide
Last checked 21 Oct 2026An experimental medicine still being studied in clinical trials. It isn't approved in Australia.
- Also calledAn experimental peptide acting on GIP, GLP-1 and glucagon pathways
- Commonly discussed forWeight management, in clinical trials (evidence is limited)
- Lab reportsNot listed
Research products sold online aren't TGA approved.
In plain English
Retatrutide is an experimental peptide that acts on three hormone pathways linked to appetite and blood sugar. It's being studied in clinical trials, and early results have drawn a lot of attention. It isn't approved by the TGA, so anything sold online is unapproved and unchecked, and its contents and quality can't be confirmed. Long-term safety is still unknown. Talk to your GP about approved options.